相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
Junyu Long et al.
EBIOMEDICINE (2019)
RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway
Xin Jin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Survival analysis and functional annotation of long non-coding RNAs in lung adenocarcinoma
Abbas Salavaty et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression
Qun Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study
Xin-Ran Tang et al.
LANCET ONCOLOGY (2018)
Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
Xinyi Guo et al.
NATURE MEDICINE (2018)
Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma
Nataliya Rohr-Udilova et al.
SCIENTIFIC REPORTS (2018)
Innate immune signaling and regulation in cancer immunotherapy
Leticia Corrales et al.
CELL RESEARCH (2017)
Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma
Sudhanshu Shukla et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma
Sudhanshu Shukla et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy
Bingshan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
Matthew D. Hellmann et al.
LANCET ONCOLOGY (2017)
New B7 Family Checkpoints in Human Cancers
Ling Ni et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
D. P. Carbone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer
Bailiang Li et al.
JAMA ONCOLOGY (2017)
Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients
Zhan Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Current state of immunotherapy for non-small cell lung cancer
Jyoti Malhotra et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2017)
An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
Lishuang Qi et al.
BRITISH JOURNAL OF CANCER (2016)
Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer
Elisabeth Brambilla et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs
Jessica J. Lin et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H. Raza Ali et al.
PLOS MEDICINE (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
Scott N. Gettinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Outdoor Particulate Matter Exposure and Lung Cancer: A Systematic Review and Meta-Analysis
Ghassan B. Hamra et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2014)
Clinical Impact of Immune Microenvironment in Stage I Lung Adenocarcinoma: Tumor Interleukin-12 Receptor β2 (IL-12Rβ2), IL-7R, and Stromal FoxP3/CD3 Ratio Are Independent Predictors of Recurrence
Kei Suzuki et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Development of Biomarkers for Screening Hepatocellular Carcinoma Using Global Data Mining and Multiple Reaction Monitoring
Hyunsoo Kim et al.
PLOS ONE (2013)
Congenital Prothrombin Deficiency: An Update
Stefano Lancellotti et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung Adenocarcinomas
Hirokazu Okayama et al.
CANCER RESEARCH (2012)
Prognostic Immune Markers in Non-Small Cell Lung Cancer
Kei Suzuki et al.
CLINICAL CANCER RESEARCH (2011)
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases
Akihiko Yoshizawa et al.
MODERN PATHOLOGY (2011)
KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases
Chen Xie et al.
NUCLEIC ACIDS RESEARCH (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
NBL1 and anillin (ANLN) genes over-expression in pancreatic carcinoma
Marek Olakowski et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2009)
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
Achim Rody et al.
BREAST CANCER RESEARCH (2009)
Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung
Marcin Skrzypski et al.
CLINICAL CANCER RESEARCH (2008)
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim et al.
IMMUNOLOGY (2007)
A translational view of the molecular pathogenesis of lung cancer
Mitsuo Sato et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway
C Suzuki et al.
CANCER RESEARCH (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Clues to CD2-associated protein involvement in cytokines
P Monzo et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Anillin binds nonmuscle myosin II and regulates the contractile ring
AF Straight et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Complete sequencing and characterization of 21,243 full-length human cDNAs
T Ota et al.
NATURE GENETICS (2004)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences
RL Strausberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Functional analysis of a human homologue of the Drosophila actin binding protein anillin suggests a role in cytokinesis
K Oegema et al.
JOURNAL OF CELL BIOLOGY (2000)
分享论文
